Fig. 8: Model showing the effect of MEX3A/TIMELESS signaling on the malignancy of ovarian cancer cells.

Abundant MEX3A regulates TIMELESS expression and performs oncogenic functions through maintaining the normal splicing of TIMELESS. At the deficiency of MEX3A, TIMELESS splicing goes wrong which leads to reduction of TIMELESS and decreases the oncogenic ability of MEX3A.